Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The current study will investigate the tolerability and efficacy of inhaled Carragelose® versus saline in hospitalized COVID-19 patients. As SARS-CoV-2 replicates readily in the lung, it is planed to apply Carragelose® in an inhalative form. Hospitalized COVID-19 patients with respiratory symptoms will inhale Inhaleen for 5 days.
Epistemonikos ID: 086e4d821da9af6172556babf3696007a3fff43c
First added on: Mar 12, 2021